Literature DB >> 27696230

Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus?

Hershel Raff1,2,3,4, Steven B Magill5.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27696230     DOI： 10.1007/s12020-016-1108-1

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  22 in total

Review 1.  Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing's syndrome?

Authors:  Therese Krarup; Thure Krarup; Claus Hagen
Journal:  Diabetes Metab Res Rev       Date:  2012-03       Impact factor: 4.876

Review 2.  Update on late-night salivary cortisol for the diagnosis of Cushing's syndrome: methodological considerations.

Authors:  Hershel Raff
Journal:  Endocrine       Date:  2013-07-10       Impact factor: 3.633

3.  Elevated salivary cortisol in the evening in healthy elderly men and women: correlation with bone mineral density.

Authors:  H Raff; J L Raff; E H Duthie; C R Wilson; E A Sasse; I Rudman; D Mattson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-09       Impact factor: 6.053

Review 4.  Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review.

Authors:  Angela C Incollingo Rodriguez; Elissa S Epel; Megan L White; Erin C Standen; Jonathan R Seckl; A Janet Tomiyama
Journal:  Psychoneuroendocrinology       Date:  2015-08-21       Impact factor: 4.905

Review 5.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

Review 6.  Cushing's Syndrome: important issues in diagnosis and management.

Authors:  James W Findling; Hershel Raff
Journal:  J Clin Endocrinol Metab       Date:  2006-07-25       Impact factor: 5.958

7.  The potential role of increased adrenal volume in the pathophysiology of obesity-related type 2 diabetes.

Authors:  A F Godoy-Matos; A R Vieira; R O Moreira; W F Coutinho; L M Carraro; D M Moreira; R Pasquali; R M R Meirelles
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

Review 8.  Is salivary gland function altered in noninsulin-dependent diabetes mellitus and obesity-insulin resistance?

Authors:  Jitjiroj Ittichaicharoen; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Arch Oral Biol       Date:  2016-01-07       Impact factor: 2.633

9.  Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients.

Authors:  Marie-Laure Nunes; Stéphanie Vattaut; Jean-Benoît Corcuff; Alexandre Rault; Hugues Loiseau; Blandine Gatta; Nathalie Valli; Luc Letenneur; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

10.  Circadian rhythm of salivary cortisol, plasma cortisol, and plasma ACTH in end-stage renal disease.

Authors:  Hershel Raff; Hariprasad Trivedi
Journal:  Endocr Connect       Date:  2012-11-19       Impact factor: 3.335
View more
  2 in total

1.  Is the hypothalamic-pituitary-adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?

Authors:  Cristina Eller-Vainicher; Alfredo Scillitani; Iacopo Chiodini
Journal:  Endocrine       Date:  2017-01-28       Impact factor: 3.633

2.  Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing's disease in an obese population.

Authors:  J Aberle; C Schulze Zur Wiesch; J Flitsch; J Veigel; G Schön; R Jung; F Reining; A Lautenbach; R Rotermund; N Riedel
Journal:  J Endocrinol Invest       Date:  2018-03-17       Impact factor: 4.256
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.